Canada markets closed

10x Genomics, Inc. (TXG)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
22.59-0.36 (-1.57%)
At close: 04:00PM EDT
22.54 -0.05 (-0.22%)
After hours: 06:26PM EDT
Show:
Income Statement
Cash Flow
Annual

Balance Sheet

All numbers in thousands
Breakdown
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Assets
Current Assets
Cash
Cash And Cash Equivalents
359,284
219,746
587,447
663,603
-
Other Short Term Investments
29,411
210,238
0
-
-
Total Cash
388,695
429,984
587,447
663,603
-
Net Receivables
114,832
104,211
85,254
51,208
-
Inventory
73,706
81,629
59,966
29,959
-
Other Current Assets
18,789
16,578
13,896
13,029
-
Total Current Assets
596,022
635,035
747,591
774,366
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
448,423
428,040
279,431
150,325
-
Accumulated Depreciation
-103,491
-68,830
-49,021
-30,502
-
Net property, plant and equipment
344,932
359,210
230,410
119,823
-
Goodwill
4,511
4,511
4,511
0
-
Intangible Assets
16,616
22,858
25,397
22,354
-
Other long-term assets
3,062
7,366
10,917
12,798
-
Total non-current assets
369,121
393,945
271,235
154,975
-
Total Assets
965,143
1,028,980
1,018,826
929,341
-
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Current Debt
-
-
-
-
9,882
Accounts Payable
15,738
21,599
17,351
4,709
-
Accrued liabilities
47,742
58,635
37,008
71,007
-
Deferred revenues
13,150
7,867
5,340
6,199
-
Other Current Liabilities
12,529
9,730
9,279
6,243
-
Total Current Liabilities
127,162
130,957
110,357
118,126
-
Non-current liabilities
Long Term Debt
-
-
-
-
19,837
Deferred revenues
8,814
3,165
-
-
834
Other long-term liabilities
4,275
2,976
8,240
3,930
-
Total non-current liabilities
96,938
92,280
90,901
72,143
-
Total Liabilities
224,100
223,237
201,258
190,269
-
Stockholders' Equity
Common Stock
2
2
2
2
-
Retained Earnings
-1,284,420
-1,029,321
-863,321
-805,098
-
Accumulated other comprehensive income
-429
-4,335
22
-50
-
Total stockholders' equity
741,043
805,743
817,568
739,072
-
Total liabilities and stockholders' equity
965,143
1,028,980
1,018,826
929,341
-